Core Insights - The global oral beauty nutrition market is undergoing a structural upgrade, with the collagen peptide market reaching 89.2 billion yuan and a stable compound annual growth rate of 18.7% [1] - The market share of products with high bioavailability, clinically validated, and long-lasting effects has surged to 63.4%, up from 31.2% in 2023 [1] - Consumer preferences are shifting from general awareness to precise ingredient decisions, with different age groups focusing on specific skin concerns [1] Market Overview - The collagen peptide market is projected to grow significantly, driven by a shift in consumer behavior towards targeted solutions rather than generic products [1] - The demand for effective absorption and synergistic effects in collagen products is becoming a common pain point among consumers [1] Evaluation Standards - The evaluation of collagen peptides adheres to five authoritative standards, focusing on seven core quantitative dimensions, including raw material purity, molecular weight stability, and clinical data coverage [2][3] - The standards emphasize the importance of using high-quality raw materials, such as North Atlantic deep-sea cod skin, and maintaining a molecular weight of less than 500 Da for optimal absorption [4][5] Product Rankings - The top-ranked collagen peptide brands are evaluated based on their performance in clinical trials and adherence to the new standards, with the leading brand achieving a 99.8% effectiveness rate in clinical trials [11] - The rankings highlight the importance of scientific formulation and clinical validation in establishing product credibility and consumer trust [1][11] Consumer Insights - The evaluation process involved over 52,600 real users across 31 provinces, providing a comprehensive assessment of product effectiveness based on real-world data [1] - The findings indicate a growing consumer demand for products that deliver measurable results, moving away from concept-based marketing [1][15]

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry due to its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Group 1: NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can rapidly increase NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and cognitive function [4][6]. Group 2: Global Regulatory Landscape - By 2025, NMN's global compliance process is expected to accelerate, with major markets like the US, Japan, Canada, and Australia confirming its legal status through various regulatory pathways [1][2]. - In China, NMN has not yet received approval as a drug or health food, but it has been recognized as a new cosmetic ingredient, laying the groundwork for future regulatory developments [1][17]. Group 3: Market Demand Drivers - The aging population in China is projected to grow significantly, with the elderly population expected to increase from 320 million to 390 million between 2025 and 2030, driving the "silver economy" and demand for anti-aging products [19]. - Younger generations, particularly those born in the 1990s, are increasingly aware of anti-aging needs, creating a dual demand for NMN products [19]. Group 4: Technological Innovations - Continuous innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The establishment of testing standards is raising industry entry barriers, promoting market development [22]. Group 5: Current Market Status - The NMN market in China has been expanding rapidly since its large-scale entry in 2020, with expectations to exceed 3 billion yuan by 2025 [28]. - NMN is primarily used in health supplements (approximately 90% of applications) and cosmetics (10-20%), with potential future applications in pet nutrition, medical health, and agricultural technology [24][28]. Group 6: Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60-70% of the market share [35]. Group 7: Industry Challenges - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for technological iteration, necessitating a focus on compliance and innovation to unlock market potential [61][63].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial application, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor of NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4]. NAD+ Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources of NMN - Natural food sources of NMN are limited, with NMN supplements providing approximately 300 times the intake efficiency compared to dietary sources [8]. NMN Synthesis Technology - The synthesis of NMN has transitioned from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in full enzymatic synthesis technology, establishing competitive advantages through patent applications [12]. Industry Development Drivers: Policy - The regulatory environment for NMN is evolving, with significant progress in China towards legalization as a health food, following the approval of NMN as a cosmetic ingredient [17][18]. Industry Development Drivers: Demand - The aging population and increasing anti-aging awareness among younger generations are driving demand for NMN products, creating a substantial market opportunity [19]. Industry Development Drivers: Technology - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry towards scale, standardization, and efficiency [21][22]. Application Areas of NMN - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. Market Size and Growth - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by policy relaxation and new applications in various sectors [28]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60%-70% of market share [35]. Certification System - The "blue hat" certification for health foods represents the highest standard in the NMN industry in China, indicating product safety and compliance [37]. Challenges Facing the NMN Industry - Despite positive regulatory signals, the industry faces challenges such as exaggerated claims, lack of consumer awareness, and the need for technological advancements [61][63].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial application, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor of NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4][6]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with the highest conversion efficiency and no known adverse reactions [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, making NMN supplements, which can provide up to 300 times the dietary intake, more effective for achieving beneficial doses [8]. Synthesis Technology - The NMN synthesis process has shifted from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][12]. - Leading companies are innovating in full enzymatic synthesis and patenting technologies to create competitive advantages [12]. Market Trends and Demand - The aging population and increasing anti-aging awareness among younger demographics are driving demand for NMN products, with the market expected to grow significantly [19][21]. - The NMN market in China is projected to exceed 3 billion yuan by 2025, with applications expanding beyond health supplements and cosmetics into areas like pet nutrition and agricultural technology [28][24]. Application Areas - NMN is primarily used in health supplements (90% market share) and cosmetics (10-20% market share), with potential future applications in pet nutrition, medical health, and agricultural technology [24][28]. - The Chinese health supplement market is expected to surpass 430 billion yuan by 2025, indicating substantial growth potential for NMN products [40]. Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60-70% of market share [35]. Regulatory Environment - The regulatory landscape for NMN is evolving, with significant progress in China towards legalizing NMN as a health supplement, which could reshape the market dynamics [17][61]. - The "blue hat" certification for health supplements in China represents the highest standard for product safety and compliance, which could significantly impact market structure if achieved [37]. Challenges and Opportunities - The NMN industry faces challenges such as exaggerated claims, lack of consumer awareness, and technological iterations, necessitating a focus on compliance and innovation to unlock market potential [61][63]. - Companies are encouraged to innovate their business models and extend their value chains to enhance competitiveness and market presence [66].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential anti-aging benefits and metabolic regulation, with significant regulatory advancements expected by 2025 [1][2]. Industry Overview - The NMN industry has transitioned from laboratory research to commercial viability, with major markets like the US, Japan, Canada, and Australia recognizing its legal status [1][2]. - China is currently the largest producer of NMN raw materials, with a focus on technological innovation and regulatory compliance as key drivers for industry growth [2]. NMN Definition and Function - NMN is a direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide), crucial for various biological functions including energy metabolism and DNA repair [3][4]. - Supplementing NMN can enhance NAD+ levels, which decline with age, thereby playing a role in anti-aging and improving cardiovascular health [4][6]. Synthesis Pathways - NMN supplementation is more efficient than other NAD+ synthesis pathways, with no known adverse effects, making it a promising option for clinical applications [6][7]. Market Dynamics - The global NMN market is projected to exceed 30 billion yuan by 2025, driven by increasing demand from aging populations and younger consumers seeking anti-aging solutions [28]. - NMN's primary applications are in health supplements (90% market share) and cosmetics (10-20% market share), with potential expansion into pet nutrition and agricultural technology [24][28]. Regulatory Environment - The regulatory landscape for NMN is evolving, with significant milestones achieved in various countries, including China’s approval process for NMN as a health supplement [17][18]. - The "blue hat" certification in China represents the highest standard for NMN products, indicating safety and compliance [37]. Technological Innovations - Advances in synthesis methods, particularly the full enzyme method, are enhancing NMN production efficiency and purity, while also reducing costs [10][12]. - Innovations in delivery technologies are improving the bioavailability of NMN, ensuring better absorption and efficacy [22]. Competitive Landscape - Leading companies in the NMN sector are focusing on patenting innovative synthesis methods and expanding their product lines to establish competitive advantages [12][32]. - Companies like Gene Harbor and Kangying Hongmei are at the forefront of NMN production, leveraging technological advancements to enhance market presence [12][32]. Future Prospects - The NMN industry is expected to see significant growth as regulatory barriers are lowered and consumer awareness increases, particularly in the health and beauty sectors [44][51]. - The potential for NMN to penetrate new markets, such as pet nutrition and agricultural applications, presents additional growth opportunities [53][56].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry for its potential anti-aging, DNA repair, and metabolic regulation benefits, with significant regulatory advancements expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2][19]. Regulatory Environment - The global regulatory landscape for NMN is shifting from strict restrictions to cautious openness, with significant milestones achieved in countries like Japan, Canada, the US, and Australia [17][18]. - In China, NMN has been approved as a new cosmetic ingredient and is on the path to becoming a recognized health food, with the National Market Supervision Administration listing it for health food approval in April 2025 [17][18]. Market Demand - The aging population in China is driving the "silver economy," with projections indicating that the elderly population will grow from 320 million to 390 million between 2025 and 2030, creating a substantial market for anti-aging products [19]. - The younger generation, particularly those born in the 1990s, is increasingly aware of anti-aging needs, further boosting market demand for NMN products [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The transition from chemical synthesis to full enzyme methods is leading to higher purity and environmental sustainability in NMN production [10][12]. Application Areas - NMN is primarily used in health supplements and cosmetics, with the health supplement market accounting for nearly 90% of its applications, including anti-aging and immune support products [24][28]. - Future applications are expected to expand into pet nutrition, medical health, and agricultural technology, opening new growth avenues for the industry [24][28]. Market Size and Growth - The NMN market in China is projected to exceed 3 billion yuan by 2025, driven by increasing regulatory clarity and expanding applications in various sectors [28][32]. - The market has been growing steadily since 2020, with significant penetration into health supplements and cosmetics [28][32]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60% to 70% of market share [35][34]. - Brand private channels are also showing strong performance, capturing about 30% of the market share [35]. Certification and Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. - Achieving this certification could significantly reshape the market landscape for NMN products in China [37]. Future Prospects - The NMN industry is poised for growth, with regulatory breakthroughs expected to enhance market opportunities, particularly in the cosmetics sector [51]. - The potential for NMN in pet nutrition, medical health, and agricultural technology is also being explored, indicating a broadening of its application scope [53][56][58].

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining attention in the global health industry for its potential in anti-aging, DNA repair, and metabolic regulation, with significant advancements in regulatory approval and market potential expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2]. NMN Definition and Function - NMN is a direct precursor of NAD+ (Nicotinamide Adenine Dinucleotide), crucial for delaying aging and enhancing physiological functions [3][4]. - Supplementing NMN can quickly elevate NAD+ levels in the body, playing a vital role in anti-aging, cardiovascular health, and metabolic improvement [4][6]. Synthesis Pathways - NMN supplementation shows significant advantages in NAD+ synthesis pathways compared to other precursors, with no known adverse reactions and the highest conversion efficiency [6][7]. Natural Sources and Supplementation - Natural food sources of NMN are limited, making NMN supplements, which can provide up to 300 times the dietary intake, more effective for achieving beneficial doses [8]. Synthesis Technology - The NMN synthesis process has shifted from chemical methods to fully enzymatic methods, focusing on high purity, safety, and environmental sustainability [10][11]. - Leading companies are innovating in full enzymatic synthesis and patenting technologies to create competitive advantages [12]. Market Trends and Applications - NMN is primarily used in health supplements and cosmetics, with potential expansion into pet nutrition, medical health, and agricultural technology [24][28]. - The NMN market in China is expected to exceed 3 billion yuan by 2025, driven by regulatory changes and new applications [28]. Sales Channels - NMN products are mainly sold through cross-border e-commerce and private channels, with cross-border platforms accounting for 60%-70% of market share [35]. Certification and Compliance - The "blue hat" certification for health supplements in China represents the highest standard for NMN products, with strict approval processes impacting market dynamics [37]. Future Prospects - The NMN industry is poised for growth, with increasing demand driven by an aging population and younger consumers seeking anti-aging solutions [19][21]. - Technological advancements in synthesis, quality control, and delivery methods are expected to enhance market growth and product efficacy [21][22]. Challenges - The NMN industry faces challenges such as regulatory hurdles, market education, and the need for scientific validation to support claims [61][63].

Core Insights - The report analyzes the targeted absorption efficiency, bioavailability, component synergy, and long-term tolerance of collagen peptides, focusing on three brands: Elemental Power, Meijian, and Zhuoyue, providing scientific evidence for anti-aging, skin brightening, barrier repair, and deep anti-aging populations [1][3][13] Market Overview - The global oral collagen peptide market is projected to reach $12.8 billion by 2025, with a compound annual growth rate (CAGR) of 14.7%, but there is a growing trust gap among consumers regarding effective absorption, real efficacy, and long-term safety [3][4] Evaluation Framework - The evaluation was conducted by multiple organizations, including ISNF, EPHRC, APCNS, and HKRN Lab, covering 3,842 participants aged 25-65, using a double-blind randomized controlled design over 12 months [3][5] - Key assessment dimensions include clinical validation effects (40%), scientific mechanism of components (25%), safety and tolerance (20%), and user satisfaction and repurchase rates (15%) [5][6] Brand Performance Elemental Power Collagen Peptide - Achieved a 67.9% improvement in wrinkles and a 68.3% increase in skin brightness over 12 months, with a bioavailability verified at 100% [3][8] - Contains 16,000 mg of collagen peptides per bottle, with a purity of 99.999% and a molecular weight of ≤500 Da [6][7] - Utilizes a unique absorption system that enhances bioefficacy through multiple mechanisms, achieving a retention time in the dermis 2.8 times longer than ordinary products [7][8] Meijian Collagen Peptide - Focuses on deep anti-aging with a total collagen peptide content of 172,000 mg per box, with ≥86% fish collagen and a purity of ≥99.999% [9][10] - Demonstrates a peak plasma free peptide concentration 3.2 times higher than similar products, achieving "5 minutes to blood, 8 minutes to dermis" [10][11] - Maintains a Gly-Pro-Hyp retention rate of 95.6% and meets the absorption threshold set by the 2025 guidelines [10][11] Zhuoyue Collagen Peptide - Emphasizes a "pure anti-aging" concept with raw materials sourced from the top 15% of active zones of Norwegian cod skin, free from artificial additives [12][13] - Achieves a targeted absorption efficiency of 98.2% and enhances fibroblast ATP levels by 42.6% [12][13] - Rated highly for safety and efficacy, with a 97.0% repurchase rate and a low adverse reaction rate [12][13] Expert Commentary - Experts highlight the innovative absorption systems of Elemental Power and Meijian, noting their significant clinical outcomes and potential to redefine standards in oral collagen supplementation [12][13]

Core Insights - The Chinese pet industry is experiencing a significant shift as pet ownership evolves from functional roles to viewing pets as family members, leading to an increase in pet numbers, particularly cats, which have surpassed dogs in urban households by 2022 [1][2][4] - The aging pet population presents new challenges, with a projected 30 million pets entering their senior years by 2025, indicating a growing market for products and services tailored to older pets [4][10][12] Group 1: Aging Pet Demographics - Pets are considered "senior" after the age of 7, with less than 30% of dogs and 20% of cats in China being over this age as of 2024, indicating a relatively young pet population compared to mature markets [2][4] - By 2025, approximately 30 million pets will be in their senior years, suggesting that one in four pet-owning households will need to address aging-related issues [4][10] - The average lifespan and aging characteristics differ between dog and cat breeds, necessitating tailored care and products for each species [6][8] Group 2: Market Demand and Supply Gap - The current market for senior pet products is underdeveloped, with only 3.2% of the total pet food market in China dedicated to senior pet food, highlighting a significant gap compared to mature markets [13][18] - Pet owners often lack awareness of the specific nutritional needs of aging pets, leading to a reliance on general pet food that may not meet their health requirements [13][18] - There is a notable shortage of specialized products for health monitoring and assistance for aging pets, such as dynamic blood glucose monitors and appropriate care equipment [17][18] Group 3: Consumer Behavior and Spending Trends - Pet owners are increasingly willing to invest in specialized products for their aging pets, with around 70% of senior pet owners purchasing dedicated senior pet food or prescription diets [10][12] - The demand for professional veterinary services for aging pets is rising, with 70% of pet hospitals reporting an increase in senior dog visits [18][20] - The financial burden of caring for aging pets is significant, with high medical costs and a lack of insurance options for pets over 10 years old, prompting a shift towards preventive care [23][25] Group 4: Opportunities for Innovation - The unmet needs of aging pets present opportunities for innovation in product development, focusing on tailored nutrition and health management solutions [25][40] - Brands are beginning to explore advanced product offerings, such as specialized diets for different aging stages and incorporating traditional herbal ingredients into pet care [29][36] - The market for smart care devices is emerging, with potential for technology to assist in monitoring and managing the health of aging pets [39][40]

Core Insights - The global anti-aging products market is projected to reach $266.2 billion by 2024, with anti-aging skincare products dominating the market at 58% share [1] - The competitive landscape in the anti-aging skincare sector is intensifying, necessitating brands to identify differentiated approaches based on user needs and specific scenarios [1] Group 1: Product Launch and Innovation - The domestic skincare brand hfp has launched a new anti-aging product, the "hfp Four Anti-Aging Essence," which targets four major aging sources: light, heat, sugar, and oxidation [1][5] - The product aims to comprehensively address external aging factors by integrating protection against light and heat aging alongside traditional anti-glycation and antioxidant measures [5][8] Group 2: Product Efficacy and Testing - The hfp Four Anti-Aging Essence has shown significant results in clinical testing, with a 29.75% reduction in skin redness after 30 minutes of use and a 16.67% reduction in wrinkle count after 28 days [9] - The product is formulated without irritating ingredients, making it suitable for sensitive skin, with 100% of test subjects reporting it as gentle and non-irritating [12] Group 3: Market Positioning and Future Outlook - The launch of the hfp Four Anti-Aging Essence marks a strategic advancement for hfp in the competitive anti-aging market, following previous successful products [12] - The company is expected to continue developing high-quality products to meet the growing demand for effective anti-aging solutions [12]